Hot Flash Drug Shows Significant, Rapid Benefits
August 23, 2024
August 23, 2024
CHARLOTTESVILLE, Virginia, Aug. 23 (TNSres) -- University of Virginia Health issued the following news release:
The investigational drug elinzanetant significantly reduces the frequency and severity of hot flashes associated with menopause while improving women's sleep and quality of life, new UVA Health research published in the prestigious Journal of the American Medical Association shows.
The nonhormonal drug, which contains no estrogen, was tested in two phase 3 tri . . .
The investigational drug elinzanetant significantly reduces the frequency and severity of hot flashes associated with menopause while improving women's sleep and quality of life, new UVA Health research published in the prestigious Journal of the American Medical Association shows.
The nonhormonal drug, which contains no estrogen, was tested in two phase 3 tri . . .